SWP
AVNS

Strategic Wealth Partners’s Avanos Medical AVNS Stock Holding History

Strategic Wealth Partners’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$420 Hold
30
– – ﹤0.01% 1334
2025
Q4 		$337 Buy
30
+29
+2,900% +$332 ﹤0.01% 1362
2025
Q3 		$12 Hold
1
– – ﹤0.01% 1307
2025
Q2 		$12 Buy
+1
New +$13 ﹤0.01% 1138
2019
Q3 		– Sell
-24
Closed -$1K – 725
2019
Q2 		$1K Buy
+24
New +$1.03K ﹤0.01% 710
2018
Q3 		– Sell
-20
Closed -$181K – 637
2018
Q2 		$181K Hold
20
– – 0.1% 147
2018
Q1 		$1K Hold
20
– – ﹤0.01% 764
2017
Q4 		$1K Buy
+20
New +$919 ﹤0.01% 720

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Strategic Wealth Partners's AVNS Position: Q1 2026 in Review

Strategic Wealth Partners held its Avanos Medical (AVNS) position steady in Q1 2026 at 30 shares worth $420. The position accounts for ﹤0.01% of the portfolio, ranked #1334.

Strategic Wealth Partners first reported a position in AVNS in Q4 2017 and has held it in 8 quarters since. The position peaked at $181K in Q2 2018. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Strategic Wealth Partners held 30 shares of Avanos Medical worth $420 as of Q1 2026.
  • Strategic Wealth Partners left its Avanos Medical share count unchanged in Q1 2026.
  • Avanos Medical made up ﹤0.01% of Strategic Wealth Partners's portfolio in Q1 2026, its #1334 holding.
  • Strategic Wealth Partners first reported a position in Avanos Medical in Q4 2017 and has held it in 8 quarters since.
  • Strategic Wealth Partners's Avanos Medical position peaked at $181K in Q2 2018.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Strategic Wealth Partners's 13F filing for Q1 2026, filed 12 May 2026.